<DOC>
	<DOC>NCT02152514</DOC>
	<brief_summary>The purpose of the study is to determine if the administration of a mix of Sufentanil and Morphine in intrathecal is a better analgesia regimen than PCA alone in patient post-VATS.</brief_summary>
	<brief_title>RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo</brief_title>
	<detailed_description>This study will compare the need for analgesia (Hydromorphone PCA) of two groups of patients post-VATS. The placebo group will only have a PCA for post-operative analgesia, witch is the standard care for patient post-VATS. The experimental group will have a intrathecal injection of a mix of morphine and sufentanil before the induction of anesthesia.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>VATS ASA 1,2 or 3 Minimum weight of 50 kg Patient able to consent Patient refusal Patient unable to understand PCA Contraindication to rachianalgesia Zona Pregnancy Over 30 mg of morphine during the last 24 hours Use of Pregabalin, Gabapentin, Doluxetin, Amitriptyline or NSAI in a context of chronic pain Severe allergic reaction to morphine, hydromorphone, sufentanil or local anesthetic Intubation over 1 hour after surgery (unability to use PCA) High risk of conversion to thoracotomy Unable to perform rachianalgesia due to technical difficulties</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>